In a clinical trial for a novel mRNA-based vaccine against a newly emerged viral pathogen, researchers measured the concentration of neutralising antibodies (IgG) in the blood of 50 volunteers over a 12-month period. The vaccine was administered in two doses: the first dose at day 0 and a booster dose at day 28. The mean antibody titres (in arbitrary units, AU) are shown below:
Day — Mean antibody titre (AU)
| 0 |
14 — 120
28 — 480
42 — 3200
90 — 2800
180 — 1500
360 — 600
A separate group of 50 volunteers who had previously recovered from natural infection with the same virus showed a mean antibody titre of
900AU at day 360 post-infection.